NLS Pharmaceutics Ltd (NLSP)
3.23
-0.26
(-7.45%)
USD |
NASDAQ |
Nov 14, 11:41
NLS Pharmaceutics Total Return Level: 3.49 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 3.49 |
November 12, 2024 | 3.90 |
November 11, 2024 | 3.97 |
November 08, 2024 | 3.94 |
November 07, 2024 | 4.15 |
November 06, 2024 | 4.09 |
November 05, 2024 | 4.04 |
November 04, 2024 | 4.39 |
November 01, 2024 | 3.60 |
October 31, 2024 | 3.63 |
October 30, 2024 | 3.86 |
October 29, 2024 | 4.13 |
October 28, 2024 | 4.11 |
October 25, 2024 | 4.18 |
October 24, 2024 | 4.26 |
October 23, 2024 | 4.605 |
October 22, 2024 | 4.84 |
October 21, 2024 | 4.760 |
October 18, 2024 | 5.30 |
October 17, 2024 | 5.18 |
October 16, 2024 | 5.08 |
October 15, 2024 | 4.77 |
October 14, 2024 | 4.59 |
October 11, 2024 | 4.45 |
October 10, 2024 | 4.25 |
Date | Value |
---|---|
October 09, 2024 | 5.096 |
October 08, 2024 | 5.28 |
October 07, 2024 | 5.064 |
October 04, 2024 | 4.90 |
October 03, 2024 | 4.875 |
October 02, 2024 | 4.98 |
October 01, 2024 | 5.20 |
September 30, 2024 | 5.07 |
September 27, 2024 | 5.20 |
September 26, 2024 | 5.00 |
September 25, 2024 | 5.292 |
September 24, 2024 | 5.56 |
September 23, 2024 | 5.424 |
September 20, 2024 | 6.04 |
September 19, 2024 | 5.476 |
September 18, 2024 | 5.472 |
September 17, 2024 | 5.692 |
September 16, 2024 | 5.44 |
September 13, 2024 | 5.408 |
September 12, 2024 | 5.28 |
September 11, 2024 | 5.164 |
September 10, 2024 | 4.96 |
September 09, 2024 | 5.028 |
September 06, 2024 | 5.22 |
September 05, 2024 | 5.684 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.49
Minimum
Nov 13 2024
234.00
Maximum
Mar 12 2021
48.86
Average
36.00
Median
Jan 31 2022
Total Return Level Benchmarks
AC Immune SA | 3.135 |
CRISPR Therapeutics AG | 49.79 |
Addex Therapeutics Ltd | 8.63 |
Molecular Partners AG | 5.51 |
MoonLake Immunotherapeutics | 51.06 |